MetaCap

Jade Biosciences Balance Sheet

NASDAQ: JBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.39+0.24 (+1.70%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Jade Biosciences financial position

At the end of fiscal 2025, Jade Biosciences reported total assets of $349.8 million, up 380.5% from a year earlier against total liabilities of $17.3 million. Shareholders' equity stood at $332.5 million, or 95.1% of assets. The company held $88.4 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 21.09, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Jade Biosciences balance sheet (annual)

Jade Biosciences annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31
Cash & Equivalents88.44M69.39M23.49M22.40M54.20M4.57M
Short-Term Investments247.72M098.95M106.82M113.18M—
Total Current Assets348.82M69.65M124.23M131.50M174.33M4.68M
Property, Plant & Equipment170.00K0288.00K242.00K186.00K39.00K
Total Assets349.78M72.80M127.42M135.30M175.36M4.71M
Accounts Payable2.15M1.29M2.40M2.58M1.21M618.00K
Total Current Liabilities16.54M12.00M17.64M7.78M2.55M1.77M
Total Liabilities17.26M119.60M17.96M8.56M2.94M1.77M
Shareholders' Equity332.52M-46.80M109.46M126.74M172.42M-13.34M
Retained Earnings-174.39M-46.98M-163.42M-87.90M-36.39M-13.41M
Net Cash (Debt)336.16M69.39M122.44M129.22M167.38M4.57M
Shares Outstanding49.32M3.67M27.76M24.72M24.41M243.08K

This table shows 6 annual periods of Jade Biosciences's balance sheet, from FY 2025 back to FY 2020, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow JBIO's reporting calendar. What is a balance sheet?

More financial data